Live Breaking News & Updates on Adelia Therapeutics

Stay updated with breaking news from Adelia therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cybin : NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS AND MANAGEMENT INFORMATION CIRCULAR - Form 6-K -September 14, 2023 at 03:02 pm EDT

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

AND

MANAGEMENT INFORMATION CIRCULAR

. ....

British Columbia , United Kingdom , District Of Columbia , United States , Province Of British Columbia , Province Of Ontario , New York , Eric Hoskins , Pharma Optionholders , Pharma Securityholders , Gabriel Fahel , Mark Lawson , Pharma Optionholder , Cybin Sars , Cybin Privateco , Aaron Bartlone , Paul Glavine , George Tziras , Doug Drysdale , Theresa Firestone , Cybin Rsus , Greg Cavers , Pharma Securityholder , European Union , Program Under Cybin , Shoppers Drug Mart ,

Cybin : CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED

JUNE 30, 2023 AND 2022

.
-Today at 07:43 am- MarketScreener ....

United States , Paul Glavine , Cybin Corp , International Accounting Standard , Natures Journey Inc , International Accounting Standards Board , International Accounting Standards , Ip Research Development , Cantor Fitzgerald Canada Corporation , Lincoln Park Capital Fund , Neo Exchange Inc , International Financial Reporting Standards , Lab Equipment , Frankfurt Stock Exchange , Mindset Pharma Inc , Serenity Life Sciences Inc , Cybin Us Holdings Inc , Cybin Inc , Adelia Therapeutics Inc , Us Securities Exchange , Cantor Fitzgerald Co , Interim Financial Reporting , Paul Glavine Director , Eric So Director , Business Corporations Act , British Columbia ,

Cybin Announces Scientific Management Transition Following Achievement of Final Adelia Milestones

- Michael Palfreyman Ph.D. and Brett Greene, who joined Cybin as part of the acquisition of Adelia Therapeutics, move into advisory roles -

- Alex Nivorozhkin Ph.D. continues as Chief Scientific. | June 5, 2023 ....

United Kingdom , United States , Doug Drysdale , Brett Greene , Exchange Commission , Health Canada , Cybin Inc , Adelia Therapeutics Inc , Drug Administration , Adelia Therapeutics , Chief Rd Officer , Chief Innovations Officer , Chief Scientific Officer , Chief Executive Officer , Clinical Milestones , Cybin Inc Stock Exchange , Press Release , Hief Cybn Ca23256x1006 ,

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Cybin Corp , Cybin Inc , Neither The Neo Exchange Inc , Drug Administration , Cybin Us Holdings Inc , Exchange Commission , Adelia Therapeutics Inc , Health Canada , Adelia Therapeutics , Transaction Agreement , Adelia Shareholders , Classb Share , Classb Shares , Neo Exchange ,

Cybin Inc. Reports Fiscal Year 2022 Financial Results and Recent Business Highlights

Cybin Inc. Reports Fiscal Year 2022 Financial Results and Recent Business Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Leah Gibson , Doug Drysdale , Company Phase , Cybin Inc , Neither The Neo Exchange Inc , Drug Administration , Entheon Biomedical Corp , World Intellectual Property Organization , Investor Relations Strategic Communications , Exchange Commission , Trademark Office , Centre For Human Drug Research , Adelia Therapeutics Inc , Health Canada , Wall Street , Chief Executive Officer , Pipeline Highlights , Review Board , Investigational New Drug , Entheon Biomedical , Human Drug Research , Kernel Flow , Strategic Milestones , Adelia Therapeutics ,